122 related articles for article (PubMed ID: 22894699)
1. In situ identification and localization of IGHA2 in the breast tumor microenvironment by mass spectrometry.
Kang S; Maeng H; Kim BG; Qing GM; Choi YP; Kim HY; Kim PS; Kim Y; Kim YH; Choi YD; Cho NH
J Proteome Res; 2012 Sep; 11(9):4567-74. PubMed ID: 22894699
[TBL] [Abstract][Full Text] [Related]
2. Proteomic molecular portrait of interface zone in breast cancer.
Kang S; Kim MJ; An H; Kim BG; Choi YP; Kang KS; Gao MQ; Park H; Na HJ; Kim HK; Yun HR; Kim DS; Cho NH
J Proteome Res; 2010 Nov; 9(11):5638-45. PubMed ID: 20857901
[TBL] [Abstract][Full Text] [Related]
3. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry.
Rauser S; Marquardt C; Balluff B; Deininger SO; Albers C; Belau E; Hartmer R; Suckau D; Specht K; Ebert MP; Schmitt M; Aubele M; Höfler H; Walch A
J Proteome Res; 2010 Apr; 9(4):1854-63. PubMed ID: 20170166
[TBL] [Abstract][Full Text] [Related]
4. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
5. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections.
Djidja MC; Francese S; Loadman PM; Sutton CW; Scriven P; Claude E; Snel MF; Franck J; Salzet M; Clench MR
Proteomics; 2009 May; 9(10):2750-63. PubMed ID: 19405023
[TBL] [Abstract][Full Text] [Related]
6. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma.
Dekker TJ; Balluff BD; Jones EA; Schöne CD; Schmitt M; Aubele M; Kroep JR; Smit VT; Tollenaar RA; Mesker WE; Walch A; McDonnell LA
J Proteome Res; 2014 Nov; 13(11):4730-8. PubMed ID: 24762205
[TBL] [Abstract][Full Text] [Related]
7. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections.
Djidja MC; Claude E; Snel MF; Scriven P; Francese S; Carolan V; Clench MR
J Proteome Res; 2009 Oct; 8(10):4876-84. PubMed ID: 19673544
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
9. Direct identification of proteins from T47D cells and murine brain tissue by matrix-assisted laser desorption/ionization post-source decay/collision-induced dissociation.
Pevsner PH; Naftolin F; Hillman DE; Miller DC; Fadiel A; Kogus A; Stern A; Samuels HH
Rapid Commun Mass Spectrom; 2007; 21(3):429-36. PubMed ID: 17216666
[TBL] [Abstract][Full Text] [Related]
10. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
[TBL] [Abstract][Full Text] [Related]
11. Primary study of lymph node metastasis-related serum biomarkers in breast cancer.
Wang L; Su D; Yan HJ; Xu JH; Zheng ZG; Hu YJ; Pan XD; Ding XW; Chen C; Chen B; Mao WM; Meng XL
Anat Rec (Hoboken); 2011 Nov; 294(11):1818-24. PubMed ID: 21964916
[TBL] [Abstract][Full Text] [Related]
12. Identification of annexin II as a novel secretory biomarker for breast cancer.
Jeon YR; Kim SY; Lee EJ; Kim YN; Noh DY; Park SY; Moon A
Proteomics; 2013 Nov; 13(21):3145-56. PubMed ID: 24019232
[TBL] [Abstract][Full Text] [Related]
13. Molecular proteomics imaging of tumor interfaces by mass spectrometry.
Kang S; Shim HS; Lee JS; Kim DS; Kim HY; Hong SH; Kim PS; Yoon JH; Cho NH
J Proteome Res; 2010 Feb; 9(2):1157-64. PubMed ID: 19821573
[TBL] [Abstract][Full Text] [Related]
14. Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.
España L; Martín B; Aragüés R; Chiva C; Oliva B; Andreu D; Sierra A
Am J Pathol; 2005 Oct; 167(4):1125-37. PubMed ID: 16192647
[TBL] [Abstract][Full Text] [Related]
15. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
16. Matrix-assisted laser desorption/ionization mass spectrometry imaging of cell cultures for the lipidomic analysis of potential lipid markers in human breast cancer invasion.
Wang S; Chen X; Luan H; Gao D; Lin S; Cai Z; Liu J; Liu H; Jiang Y
Rapid Commun Mass Spectrom; 2016 Feb; 30(4):533-42. PubMed ID: 26777684
[TBL] [Abstract][Full Text] [Related]
17. SELDI-MS-based expression profiling of ductal invasive and lobular invasive human breast carcinomas.
Traub F; Feist H; Kreipe HH; Pich A
Pathol Res Pract; 2005; 201(12):763-70. PubMed ID: 16308101
[TBL] [Abstract][Full Text] [Related]
18. Rapid identification of differentiation markers from whole epithelial cells by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry and statistical analysis.
Marvin-Guy LF; Duncan P; Wagnière S; Antille N; Porta N; Affolter M; Kussmann M
Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1099-108. PubMed ID: 18335464
[TBL] [Abstract][Full Text] [Related]
19. Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.
Dowling P; Maurya P; Meleady P; Glynn SA; Dowd AJ; Henry M; Clynes M
Anticancer Res; 2007; 27(3A):1309-17. PubMed ID: 17593624
[TBL] [Abstract][Full Text] [Related]
20. Combination of immunohistochemistry and laser ablation ICP mass spectrometry for imaging of cancer biomarkers.
Seuma J; Bunch J; Cox A; McLeod C; Bell J; Murray C
Proteomics; 2008 Sep; 8(18):3775-84. PubMed ID: 18712769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
